Clinical Trials Browser

Phase 2 × Gastric Adenocarcinoma × apatinib × Clear all

NCT07464756 2026-03-11

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Gastric Adenocarcinoma